Roland Bruno Walter (Roland B Walter, R B Walter)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 117

Top Venues

Leukemia

Cancers

Leukemia & lymphoma

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Daniel J Olivieri, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M Sandmaier, Irum Khan, Chris Davis, Ryan S Basom, Frederick R Appelbaum, Roland Bruno Walter
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leukemia 38 (4) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Roland Bruno Walter, Robert Peter Gale
Measurable residual disease in haematological and solid cancers. Leukemia (2024)
Roland Bruno Walter, Robert Peter Gale
Measurable residual disease in haematological and solid cancers. Leukemia 38 (8) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Daniel J Olivieri, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M Sandmaier, Irum Khan, Chris Davis, Ryan S Basom, Frederick R Appelbaum, Roland Bruno Walter
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leukemia (2024)
Daniel J Olivieri, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M Sandmaier, Irum Khan, Chris Davis, Ryan S Basom, Frederick R Appelbaum, Roland Bruno Walter
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leukemia (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Filippo Milano, Calvin M Le, Brenda M Sandmaier, Bart L Scott, Frederick R Appelbaum, Roland Bruno Walter
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML. American journal of hematology 99 (5) (2024)
Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Filippo Milano, Calvin M Le, Brenda M Sandmaier, Bart L Scott, Frederick R Appelbaum, Roland Bruno Walter
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML. American journal of hematology 99 (5) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Farhad Ravandi, Marion Subklewe, Roland Bruno Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D Baldus, Lars Fransecky, Timothy S Pardee, Hagop M Kantarjian, Priscilla K Yen, Lata Mukundan, Bharat Panwar, Marc R Yago, Suresh Agarwal, Sophia K Khaldoyanidi, Anthony Stein
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study. Leukemia & lymphoma (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Margaret C Lunn-Halbert, George S Laszlo, Sarah Erraiss, Mark T Orr, Heidi K Jessup, Heather J Thomas, Henry Chan, Mahan A Jahromi, Jonathan Lloyd, Ann F Cheung, Gregory P Chang, Tanmay Dichwalkar, Daniel Fallon, Asya Grinberg, Eduardo Rodríguez-Arbolí, Sheryl Y T Lim, Allie R Kehret, Jenny Huo, Frances M Cole, Samuel C Scharffenberger, Roland Bruno Walter
Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET ® CC-96191. Cancers 16 (5) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia (2024)
Daniel J Olivieri, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M Sandmaier, Irum Khan, Chris Davis, Ryan S Basom, Frederick R Appelbaum, Roland Bruno Walter
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leukemia 38 (4) (2024)
Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Filippo Milano, Calvin M Le, Brenda M Sandmaier, Bart L Scott, Frederick R Appelbaum, Roland Bruno Walter
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML. American journal of hematology 99 (5) (2024)
Margaret C Lunn-Halbert, George S Laszlo, Sarah Erraiss, Mark T Orr, Heidi K Jessup, Heather J Thomas, Henry Chan, Mahan A Jahromi, Jonathan Lloyd, Ann F Cheung, Gregory P Chang, Tanmay Dichwalkar, Daniel Fallon, Asya Grinberg, Eduardo Rodríguez-Arbolí, Sheryl Y T Lim, Allie R Kehret, Jenny Huo, Frances M Cole, Samuel C Scharffenberger, Roland Bruno Walter
Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET ® CC-96191. Cancers 16 (5) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Filippo Milano, Calvin M Le, Brenda M Sandmaier, Bart L Scott, Frederick R Appelbaum, Roland Bruno Walter
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML. American journal of hematology 99 (5) (2024)
Eduardo Rodríguez-Arbolí, Megan K D Othus, Sylvie D Freeman, Francesco Buccisano, Lok Lam Ngai, Ian Thomas, Raffaele Palmieri, Jacqueline Cloos, Sean Johnson, Elisa Meddi, Nigel H Russell, Adriano Venditti, Patrycja Gradowska, Gert J Ossenkoppele, Bob Löwenberg, Roland Bruno Walter
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML). Leukemia (2024)
Scott R Solomon, Bayard L Powell, Jamie Koprivnikar, Catherine Lai, Heather Male, Laura C Michaelis, Laura F Newell, David Sanford, Jack Jenkins, Amy Zelaya, Sheryl Coppola, Stefan Faderl, Roland Bruno Walter
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial. Cancers 16 (5) (2024)
Megan K D Othus, Domitilla Baccon, Naveed Ali, Eduardo Rodríguez-Arbolí, Corentin Orvain, Filippo Milano, Brenda M Sandmaier, Chris Davis, Ryan S Basom, Roland Bruno Walter
Relationship between morphologic remission with or without hematologic recovery and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia. Bone marrow transplantation (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Roland Bruno Walter, Victoria Potter, Charles F Craddock
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Adults over 70 years old. Blood (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Daniel J Olivieri, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M Sandmaier, Irum Khan, Chris Davis, Ryan S Basom, Frederick R Appelbaum, Roland Bruno Walter
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leukemia 38 (4) (2024)
Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Filippo Milano, Calvin M Le, Brenda M Sandmaier, Bart L Scott, Frederick R Appelbaum, Roland Bruno Walter
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML. American journal of hematology (2024)
Farhad Ravandi, Marion Subklewe, Roland Bruno Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D Baldus, Lars Fransecky, Timothy S Pardee, Hagop M Kantarjian, Priscilla K Yen, Lata Mukundan, Bharat Panwar, Marc R Yago, Suresh Agarwal, Sophia K Khaldoyanidi, Anthony Stein
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study. Leukemia & lymphoma 65 (9) (2024)
Eduardo Rodríguez-Arbolí, Megan K D Othus, Sylvie D Freeman, Francesco Buccisano, Lok Lam Ngai, Ian Thomas, Raffaele Palmieri, Jacqueline Cloos, Sean Johnson, Elisa Meddi, Nigel H Russell, Adriano Venditti, Patrycja Gradowska, Gert J Ossenkoppele, Bob Löwenberg, Roland Bruno Walter
Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML). Leukemia (2024)
Corentin Orvain, Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Filippo Milano, Calvin M Le, Brenda M Sandmaier, Bart L Scott, Frederick R Appelbaum, Roland Bruno Walter
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML. American journal of hematology (2024)
Farhad Ravandi, Marion Subklewe, Roland Bruno Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D Baldus, Lars Fransecky, Timothy S Pardee, Hagop M Kantarjian, Priscilla K Yen, Lata Mukundan, Bharat Panwar, Marc R Yago, Suresh Agarwal, Sophia K Khaldoyanidi, Anthony Stein
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study. Leukemia & lymphoma 65 (9) (2024)
Margaret C Lunn-Halbert, George S Laszlo, Sarah Erraiss, Mark T Orr, Heidi K Jessup, Heather J Thomas, Henry Chan, Mahan A Jahromi, Jonathan Lloyd, Ann F Cheung, Gregory P Chang, Tanmay Dichwalkar, Daniel Fallon, Asya Grinberg, Eduardo Rodríguez-Arbolí, Sheryl Y T Lim, Allie R Kehret, Jenny Huo, Frances M Cole, Samuel C Scharffenberger, Roland Bruno Walter
Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET ® CC-96191. Cancers 16 (5) (2024)
Daniel J Olivieri, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M Sandmaier, Irum Khan, Chris Davis, Ryan S Basom, Frederick R Appelbaum, Roland Bruno Walter
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leukemia 38 (4) (2024)
John J Lim, Megan K D Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Time independent factors that predict relapse in adults with acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Scott R Solomon, Bayard L Powell, Jamie Koprivnikar, Catherine Lai, Heather Male, Laura C Michaelis, Laura F Newell, David Sanford, Jack Jenkins, Amy Zelaya, Sheryl Coppola, Stefan Faderl, Roland Bruno Walter
CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial. Cancers 16 (5) (2024)
Daniel J Olivieri, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Filippo Milano, Brenda M Sandmaier, Irum Khan, Chris Davis, Ryan S Basom, Frederick R Appelbaum, Roland Bruno Walter
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Leukemia (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Corentin Orvain, Eduardo Rodríguez-Arbolí, Megan Othus, Brenda M Sandmaier, H Joachim Deeg, Frederick R Appelbaum, Roland Bruno Walter
Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia. Cancers 15 (2) (2023)
George S Laszlo, Brenda M Sandmaier, Allie R Kehret, Johnnie J Orozco, Donald K Hamlin, Shannon L Dexter, Sheryl Y T Lim, Frances M Cole, Jenny Huo, D Scott Wilbur, Roland Bruno Walter
[ 211 At]astatine-based anti-CD22 radioimmunotherapy for B-cell malignancies. Leukemia & lymphoma (2023)
Michelle Y Zhang, Megan Othus, Carole Shaw, Kelda G Schonhoff, Anna B Halpern, Jacob Appelbaum, Paul C Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents. Leukemia & lymphoma (2023)
Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival, Ryan D Cassaday, Vivian G Oehler, Pamela S Becker, Jacob S Appelbaum, Janis L Abkowitz, Johnnie J Orozco, Sioban B Keel, Paul C Hendrie, Bart L Scott, Cristina Maria M Ghiuzeli, Elihu Estey, Roland Bruno Walter
Phase 1/2 Study of Sorafenib Added to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone in Untreated AML. Blood advances (2023)
Corentin Orvain, Eduardo Rodríguez-Arbolí, Megan Othus, Brenda M Sandmaier, H Joachim Deeg, Frederick R Appelbaum, Roland Bruno Walter
Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia. Cancers 15 (2) (2023)
Corentin Orvain, Eduardo Rodríguez-Arbolí, Megan Othus, Brenda M Sandmaier, H Joachim Deeg, Frederick R Appelbaum, Roland Bruno Walter
Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia. Cancers 15 (2) (2023)
Noam E Kopmar, Ted Gooley, Niall Curley, Kathryn Russell, Carole Shaw, Kelda Schonhoff, John Lim, Anna B Halpern, Roland Bruno Walter, Bart L Scott, Jacob Appelbaum, Paul C Hendrie, Elihu H Estey, Mary-Elizabeth M Percival
Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms. Leukemia & lymphoma (2023)
Corentin Orvain, Eduardo Rodríguez-Arbolí, Megan Othus, Brenda M Sandmaier, H Joachim Deeg, Frederick R Appelbaum, Roland Bruno Walter
Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia. Cancers 15 (2) (2023)
Lauren Shih, Megan Othus, Kelda Schonhoff, Carole Shaw, Jacob S Appelbaum, Anna B Halpern, Pamela S Becker, Roland Bruno Walter, Elihu Estey, Mary-Elizabeth M Percival
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms. Leukemia (2023)
Roland Bruno Walter
Perspective on measurable residual disease testing in acute myeloid leukemia. Leukemia (2023)
Julian Lindsay, Carla S Walti, Anna B Halpern, Hu Xie, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Guang-Shing Cheng, Louise Kimball, Wendy M Leisenring, Matthew Greenwood, Sharon C-A Chen, David Cm Kong, Monica A Slavin, Michael Boeckh, David Fredricks, Catherine Liu, Mirta Maravilla Rosas, Roland Bruno Walter, Joshua A Hill
Invasive Fungal Infections After CLAG-M/CLAG Chemotherapy for Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms. Blood advances (2023)
Ryan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, Olga Sala-Torra, Philip A Stevenson, Christen H Martino, Yajuan J Liu, Min Fang, Mary-Elizabeth M Percival, Anna B Halpern, Pamela S Becker, Vivian G Oehler, Andrei R Shustov, Jason P Cooper, Johnnie J Orozco, Paul C Hendrie, Roland Bruno Walter, Jerald P Radich, Lorinda A Soma, Elihu H Estey
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia. Leukemia & lymphoma (2023)
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Colleen Delaney, Catherine Liu, Steven A Pergam, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Michael Boeckh, Roland Bruno Walter, Joshua A Hill
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia 37 (2) (2022)
Eduardo Rodríguez-Arbolí, Corentin Orvain, Megan K D Othus, Roland Bruno Walter
Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation. Bone marrow transplantation 57 (11) (2022)
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Colleen Delaney, Catherine Liu, Steven A Pergam, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Michael Boeckh, Roland Bruno Walter, Joshua A Hill
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia 37 (2) (2022)
Gabrielle Paras, Megan Othus, Kelda Schonhoff, Carole Shaw, Mohamed Lotfy Sorror, Anna B Halpern, Jacob S Appelbaum, Paul Hendrie, Roland Bruno Walter, Elihu H Estey, Mary-Elizabeth M Percival
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms. Leukemia (2022)
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Colleen Delaney, Catherine Liu, Steven A Pergam, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Michael Boeckh, Roland Bruno Walter, Joshua A Hill
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia 37 (2) (2022)
Anna B Halpern, Megan K D Othus, Genevieve Alcorn, Zahra Ali, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival, Siobán B Keel, Ryan D Cassaday, Pamela S Becker, Elihu H Estey, Roland Bruno Walter
Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasm. Leukemia 36 (5) (2022)
Corentin Orvain, Megan K D Othus, Gurleen Johal, Mathilde M Hunault-Berger, Frederick R Appelbaum, Roland Bruno Walter
Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemia. Leukemia 36 (8) (2022)
Naveen Pemmaraju, Hagop M Kantarjian, Kendra L Sweet, Eunice S Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Y Konopleva, Arthur E Frankel, Vikas K Gupta, Ruben A Mesa, Matthew L Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James R Mason, Maria Teresa García-Romero, Norma C Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland Bruno Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K Rampal, Marcos de Lima, James M Foran, Amir T Fathi, Aric C Hall, Meagan A Jacoby, Jeffrey E Lancet, Gabriel N Mannis, Anthony S Stein, Alice S Mims, David A Rizzieri, Rebecca L Olin, Alexander E Perl, Gary J Schiller, Paul J Shami, Richard M Stone, Stephen A Strickland, Matthew J Wieduwilt, Naval G Daver, Farhad Ravandi, Sumithira Vasu, Monica L Guzman, Gail J Roboz, Joseph D Khoury, Muzaffar H Qazilbash, Leomar Y Ballester, Branko Cuglievan, Yazan F Madanat, Mohamed A Kharfan-Dabaja, Anna B Pawlowska, Justin Taylor, Martin S Tallman, Prajwal Dhakal, Andrew A Lane
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need. Blood (2022)
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Colleen Delaney, Catherine Liu, Steven A Pergam, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Michael Boeckh, Roland Bruno Walter, Joshua A Hill
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia (2022)
George S Laszlo, Johnnie J Orozco, Allie R Kehret, Margaret C Lunn-Halbert, Jenny Huo, Donald K Hamlin, D Scott Wilbur, Shannon L Dexter, Melissa L Comstock, Shyril O'Steen, Brenda M Sandmaier, Damian J Green, Roland Bruno Walter
Development of [ 211 At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies. Leukemia 36 (6) (2022)
Nicole Mostofi, Carole Shaw, Roland Bruno Walter, Mary-Elizabeth M Percival, Elihu H Estey
Evaluating concordance in assessment of ECOG performance status in acute myeloid leukemia patients. Leukemia 36 (10) (2022)
Raffaele Palmieri, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Roland Bruno Walter, Adriano Venditti, Francesco Buccisano
Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia. Cancers 15 (1) (2022)
Roland Bruno Walter, Brenda M Sandmaier, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Masumi Ueda Oshima, Gary Schoch, Chris Davis, H Joachim Deeg, Rainer F Storb
Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission. Bone marrow transplantation (2022)
Christophe Desprez, Jérémie Riou, Pierre Peterlin, Tony Marchand, Marie-Anne Couturier, Alban Villate, Jean-Baptiste Mear, Patrice Chevalier, Gaelle Guillerm, Emmanuel Gyan, Aline Schmidt-Tanguy, Roland Bruno Walter, Mathilde M Hunault-Berger, Corentin Orvain
Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia-a Grand Ouest Against Leukemia (GOAL) study. Leukemia 36 (10) (2022)
Raffaele Palmieri, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Roland Bruno Walter, Adriano Venditti, Francesco Buccisano
Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia. Cancers 15 (1) (2022)
Gabrielle Paras, Linde M Morsink, Megan Othus, Filippo Milano, Brenda M Sandmaier, Lucas C Zarling, Raffaele Palmieri, Gary Schoch, Chris Davis, Marie Bleakley, Mary E D Flowers, H Joachim Deeg, Frederick R Appelbaum, Rainer F Storb, Roland Bruno Walter
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML. Blood 139 (11) (2022)
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Colleen Delaney, Catherine Liu, Steven A Pergam, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Michael Boeckh, Roland Bruno Walter, Joshua A Hill
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia 37 (2) (2022)
Lucas C Zarling, Megan K D Othus, Brenda M Sandmaier, Filippo Milano, Gary Schoch, Chris Davis, Marie Bleakley, H Joachim Deeg, Frederick R Appelbaum, Rainer F Storb, Roland Bruno Walter
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation. Leukemia 36 (6) (2022)
Raffaele Palmieri, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Roland Bruno Walter, Adriano Venditti, Francesco Buccisano
Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia. Cancers 15 (1) (2022)
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Colleen Delaney, Catherine Liu, Steven A Pergam, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Michael Boeckh, Roland Bruno Walter, Joshua A Hill
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia 37 (2) (2022)
Roland Bruno Walter, Brenda M Sandmaier, Megan K D Othus, Corentin Orvain, Eduardo Rodríguez-Arbolí, Masumi Ueda Oshima, Gary Schoch, Chris Davis, H Joachim Deeg, Rainer F Storb
Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission. Bone marrow transplantation (2022)
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Colleen Delaney, Catherine Liu, Steven A Pergam, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Michael Boeckh, Roland Bruno Walter, Joshua A Hill
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia 37 (2) (2022)
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung, Kelda G Schonhoff, Emily M Huebner, Colleen Delaney, Catherine Liu, Steven A Pergam, Guang-Shing Cheng, Louise E Kimball, Wendy M Leisenring, Michael Boeckh, Roland Bruno Walter, Joshua A Hill
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms. Leukemia (2022)
Colin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, Anna B Halpern, Jacob S Appelbaum, Mary-Elizabeth M Percival, Paul C Hendrie, Vivian G Oehler, Siobán B Keel, Janis L Abkowitz, Jason P Cooper, Ryan D Cassaday, Elihu H Estey, Roland Bruno Walter
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms. Cancers 14 (12) (2022)
Noam E Kopmar, Megan K D Othus, Kelda M Gardner, Carole Shaw, Anna B Halpern, Bart L Scott, Paul C Hendrie, Roland Bruno Walter, Pamela S Becker, Elihu H Estey, Mary-Elizabeth M Percival
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies. Leukemia 36 (4) (2022)
Nicholas James Short, Chenqi Fu, Donald A Berry, Roland Bruno Walter, Sylvie D Freeman, Christopher S Hourigan, Xuelin Huang, Graciela Nogueras Gonzalez, Hyunsoo Hwang, Xinyue Qi, Hagop M Kantarjian, Shouhao Zhou, Farhad Ravandi
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis. Leukemia 36 (12) (2022)
Elizabeth F Krakow, Roland Bruno Walter, Julia M Nathe, Tess Perez, Ali Ahmed, Nayak Polissar, Ljubomir Miljacic, Anna B Halpern, Mary Evelyn Flowers, Elihu H Estey
Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation. American journal of hematology 97 (6) (2022)
Roland Bruno Walter, Robert Peter Gale
Elihu H. Estey, MD: Leukaemia expert, statistician, and gentle soul (July 15, 1946-October 8, 2021). Bone marrow transplantation (2021)
Sabine Kayser, Robert K Hills, Ralitsa Langova, Michael Kramer, Francesca Guijarro, Zuzana Sustkova, Elihu H Estey, Carole M Shaw, Zdenek Rácil, Jiri Mayer, Pavel Zak, Maria R Baer, Andrew M Brunner, Tomas Szotkowski, Petr Cetkovsky, David Grimwade, Roland Bruno Walter, Alan K Burnett, Anthony D Ho, Gerhard Ehninger, Carsten Müller-Tidow, Uwe Platzbecker, Christian Thiede, Christoph Röllig, Angela Schulz, Gregor Warsow, Benedikt Brors, Jordi Esteve, Nigel H Russell, Richard F Schlenk, Mark J Levis
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study. British journal of haematology 192 (5) (2021)
Roland Bruno Walter, Andreas Hochhaus, Robert Peter Gale
Elihu H. Estey, MD: leukemia expert, statistician, and gentle soul (July 15, 1946-October 8, 2021). Leukemia 35 (12) (2021)
Kelsey-Leigh A Garcia, Sindhu Cherian, Philip A Stevenson, Christen H Martino, Andrei R Shustov, Pamela S Becker, Mary-Elizabeth M Percival, Vivian G Oehler, Anna B Halpern, Roland Bruno Walter, Johnnie J Orozco, Siobán B Keel, Elihu H Estey, Ryan D Cassaday
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia. Cancer 128 (7) (2021)
Colin D Godwin, George S Laszlo, Salvatore Fiorenza, Eliotte E Garling, Tinh-Doan Phi, Olivia M Bates, Colin E Correnti, Benjamin G Hoffstrom, Margaret C Lunn-Halbert, Olivier Humbert, Hans-Peter Kiem, Cameron J Turtle, Roland Bruno Walter
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy. Leukemia 35 (9) (2021)
Michael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, Francesco Buccisano, Christopher S Hourigan, Lok Lam Ngai, Jesse Marc Tettero, Costa Bachas, Constance Baer, Marie Christine Bene, Veit L Bücklein, Anna Czyz, Barbara Denys, Richard Dilon, Michaela Feuring-Buske, Monica L Guzman, Torsten Haferlach, Lina Han, Julia K Herzig, Jeffrey L Jorgensen, Wolfgang Kern, Marina Y Konopleva, Francis Lacombe, Marta Libura, Agata Majchrzak, Luca Maurillo, Yishai Ofran, Jan Philippé, Adriana Plesa, Claude Preudhomme, Farhad Ravandi, Christophe Roumier, Marion Subklewe, Felicitas Thol, Arjan A van de Loosdrecht, Bert A van der Reijden, Adriano Venditti, Agnieszka Świątek, Peter J M Valk, Brent L Wood, Roland Bruno Walter, Christian Thiede, Konstanze Döhner, Gail J Roboz, Jacqueline Cloos
2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document. Blood (2021)
Anna B Halpern, Megan Othus, Nicholas P Howard, Paul C Hendrie, Mary-Elizabeth M Percival, Garrett A Hartley, Verna L Welch, Elihu H Estey, Roland Bruno Walter
Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy. Leukemia & lymphoma (2021)
Roland Bruno Walter, Yishai Ofran, Agnieszka Wierzbowska, Farhad Ravandi, Christopher S Hourigan, Lok Lam Ngai, Adriano Venditti, Francesco Buccisano, Gert J Ossenkoppele, Gail J Roboz
Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations. Leukemia 35 (6) (2021)
Shenmiao Yang, Neil E Kay, Min Shi, Gert Ossenkoppele, Roland Bruno Walter, Robert Peter Gale
Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both? Leukemia 35 (12) (2021)
Linde M Morsink, Brenda M Sandmaier, Megan Othus, Raffaele Palmieri, Noa Granot, Evandro D Bezerra, Brent L Wood, Marco B Mielcarek, Gary Schoch, Chris Davis, Mary E D Flowers, H Joachim Deeg, Frederick R Appelbaum, Rainer Storb, Roland Bruno Walter
Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Cancers 12 (9) (2020)
Utkarsh H Acharya, Roland Bruno Walter
Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML). Cancers 12 (12) (2020)
Colin D Godwin, Olivia M Bates, Eliotte E Garling, Mary E Beddoe, George S Laszlo, Roland Bruno Walter
The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity. British journal of haematology 189 (1) (2020)
Linde M Morsink, Megan K D Othus, Evandro D Bezerra, Brent L Wood, Min Fang, Brenda M Sandmaier, Marco B Mielcarek, Gary Schoch, Rainer F Storb, H Joachim Deeg, Frederick R Appelbaum, Roland Bruno Walter
Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML. Leukemia 34 (6) (2020)
Roland Bruno Walter, Frederick R Appelbaum, Elihu H Estey
Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia. Leukemia 35 (2) (2020)
Linde M Morsink, Evandro D Bezerra, Megan K D Othus, Brent L Wood, Min Fang, Brenda M Sandmaier, Marco B Mielcarek, H Joachim Deeg, Gary Schoch, Frederick R Appelbaum, Roland Bruno Walter
Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease. Leukemia 34 (6) (2019)

Roland Bruno Walter.css-eqlu8i{font-size:small;padding-left:4px;} (Roland B Walter, R B Walter)

Publication Activity (10 Years)

Top Topics

Top Venues

Roland Bruno Walter (Roland B Walter, R B Walter)